145 related articles for article (PubMed ID: 24337855)
41. Risk gene variants for nicotine dependence in the CHRNA5-CHRNA3-CHRNB4 cluster are associated with cognitive performance.
Winterer G; Mittelstrass K; Giegling I; Lamina C; Fehr C; Brenner H; Breitling LP; Nitz B; Raum E; Müller H; Gallinat J; Gal A; Heim K; Prokisch H; Meitinger T; Hartmann AM; Möller HJ; Gieger C; Wichmann HE; Illig T; Dahmen N; Rujescu D
Am J Med Genet B Neuropsychiatr Genet; 2010 Dec; 153B(8):1448-58. PubMed ID: 20886544
[TBL] [Abstract][Full Text] [Related]
42. Variant within the promoter region of the CHRNA3 gene associated with FTN dependence is not related to self-reported willingness to quit smoking.
Marques-Vidal P; Kutalik Z; Paccaud F; Bergmann S; Waeber G; Vollenweider P; Cornuz J
Nicotine Tob Res; 2011 Sep; 13(9):833-9. PubMed ID: 21511889
[TBL] [Abstract][Full Text] [Related]
43. Susceptibility locus for lung cancer at 15q25.1 is not associated with risk of pancreatic cancer.
Chen J; Wu X; Pande M; Amos CI; Killary AM; Sen S; Frazier ML
Pancreas; 2011 Aug; 40(6):872-5. PubMed ID: 21697764
[TBL] [Abstract][Full Text] [Related]
44. [Interaction research on smoking and microRNA genes SNP related to lung cancer in Fujian Han population].
He F; Lin J; Yu T; Zhang X; Liu Z; Xiong W; Cai L
Zhonghua Yu Fang Yi Xue Za Zhi; 2016 Feb; 50(2):168-74. PubMed ID: 26926727
[TBL] [Abstract][Full Text] [Related]
45. CHRNA3 rs1051730 genotype and short-term smoking cessation.
Munafò MR; Johnstone EC; Walther D; Uhl GR; Murphy MF; Aveyard P
Nicotine Tob Res; 2011 Oct; 13(10):982-8. PubMed ID: 21690317
[TBL] [Abstract][Full Text] [Related]
46. Association between a 15q25 gene variant, smoking quantity and tobacco-related cancers among 17 000 individuals.
Lips EH; Gaborieau V; McKay JD; Chabrier A; Hung RJ; Boffetta P; Hashibe M; Zaridze D; Szeszenia-Dabrowska N; Lissowska J; Rudnai P; Fabianova E; Mates D; Bencko V; Foretova L; Janout V; Field JK; Liloglou T; Xinarianos G; McLaughlin J; Liu G; Skorpen F; Elvestad MB; Hveem K; Vatten L; Study E; Benhamou S; Lagiou P; Holcátová I; Merletti F; Kjaerheim K; Agudo A; Castellsagué X; Macfarlane TV; Barzan L; Canova C; Lowry R; Conway DI; Znaor A; Healy C; Curado MP; Koifman S; Eluf-Neto J; Matos E; Menezes A; Fernandez L; Metspalu A; Heath S; Lathrop M; Brennan P
Int J Epidemiol; 2010 Apr; 39(2):563-77. PubMed ID: 19776245
[TBL] [Abstract][Full Text] [Related]
47. Association Between CHRNA3 and CHRNA5 Nicotine Receptor Subunit Gene Variants and Nicotine Dependence in an Isolated Populationof Kashubians in Poland.
Kita-Milczarska K; Sieminska A; Jassem E
Med Sci Monit; 2016 Apr; 22():1442-50. PubMed ID: 27127891
[TBL] [Abstract][Full Text] [Related]
48. CHRNA3 and CYP3A5*3 genotype, lung function and chronic obstructive pulmonary disease in the general population.
Kaur-Knudsen D; Bojesen SE; Nordestgaard BG
Pharmacogenet Genomics; 2014 Apr; 24(4):220-9. PubMed ID: 24535486
[TBL] [Abstract][Full Text] [Related]
49. The effect of CHRNA3 rs1051730 C>T and ABCB1 rs3842 A>G polymorphisms on non-small cell lung cancer and nicotine dependence in Iranian population.
Veiskarami P; Houshmand M; Seifi S; Ansarinejad N; Fardad F; Abbasi B
Heliyon; 2021 Sep; 7(9):e07867. PubMed ID: 34522797
[TBL] [Abstract][Full Text] [Related]
50. Association of the CHRNA5-A3-B4 gene cluster with heaviness of smoking: a meta-analysis.
Ware JJ; van den Bree MB; Munafò MR
Nicotine Tob Res; 2011 Dec; 13(12):1167-75. PubMed ID: 22071378
[TBL] [Abstract][Full Text] [Related]
51. [DNA damage associated genetic variants contribute to lung cancer susceptibility in a Han Chinese population].
Li ZH; Wang YZ; Liu J; Zhu M; Du JB; Yuan J; Chen WH; Zhang ZD; Hu ZB; Wu TC; Shen HB
Zhonghua Yu Fang Yi Xue Za Zhi; 2016 Aug; 50(8):721-7. PubMed ID: 27539526
[TBL] [Abstract][Full Text] [Related]
52. Association of smoking with tumor size at diagnosis in non-small cell lung cancer.
Chen X; Gorlov IP; Merriman KW; Weng SF; Foy M; Keener G; Amos CI; Spitz MR; Kimmel M; Gorlova OY
Lung Cancer; 2011 Dec; 74(3):378-83. PubMed ID: 21645942
[TBL] [Abstract][Full Text] [Related]
53. Role of CHRNA5-A3 genetic Locus variants and developing drug for chronic obstructive pulmonary disease.
Lococo F; Cesario A; Petracca-Ciavarella L; Granone P; Russo P
Curr Med Chem; 2012; 19(34):5863-70. PubMed ID: 23061658
[TBL] [Abstract][Full Text] [Related]
54. New associations of the genetic polymorphisms in nicotinic receptor genes with the risk of lung cancer.
Chikova A; Bernard HU; Shchepotin IB; Grando SA
Life Sci; 2012 Nov; 91(21-22):1103-8. PubMed ID: 22280835
[TBL] [Abstract][Full Text] [Related]
55. Cholinergic receptor nicotinic alpha 5 subunit polymorphisms are associated with smoking cessation success in women.
Tomaz PRX; Santos JR; Scholz J; Abe TO; Gaya PV; Negrão AB; Krieger JE; Pereira AC; Santos PCJL
BMC Med Genet; 2018 Apr; 19(1):55. PubMed ID: 29621993
[TBL] [Abstract][Full Text] [Related]
56. Nicotinic acetylcholine receptor gene polymorphism is not associated with tobacco-related oral squamous cell carcinoma.
Rajesh D; Azeem Mohiyuddin SM; Balakrishna S; Kutty AVM
Indian J Cancer; 2018; 55(4):399-403. PubMed ID: 30829278
[TBL] [Abstract][Full Text] [Related]
57. Association between genetic variants on chromosome 15q25 locus and several nicotine dependence traits in Polish population: a case-control study.
Buczkowski K; Sieminska A; Linkowska K; Czachowski S; Przybylski G; Jassem E; Grzybowski T
Biomed Res Int; 2015; 2015():350348. PubMed ID: 25632390
[TBL] [Abstract][Full Text] [Related]
58. Association Between rs1051730 and Smoking During Pregnancy in Dutch Women.
Mbarek H; van Beijsterveldt CEM; Jan Hottenga J; Dolan CV; Boomsma DI; Willemsen G; Vink JM
Nicotine Tob Res; 2019 May; 21(6):835-840. PubMed ID: 29228387
[TBL] [Abstract][Full Text] [Related]
59. Genetic polymorphism rs3760396 of the chemokine (C-C motif) ligand 2 gene (CCL2) associated with the susceptibility of lung cancer in a pathological subtype-specific manner in Han-ancestry Chinese: a case control study.
Li X; Lin F; Zhou H
BMC Cancer; 2016 May; 16():298. PubMed ID: 27145753
[TBL] [Abstract][Full Text] [Related]
60. Epigenetic screen identifies genotype-specific promoter DNA methylation and oncogenic potential of CHRNB4.
Scherf DB; Sarkisyan N; Jacobsson H; Claus R; Bermejo JL; Peil B; Gu L; Muley T; Meister M; Dienemann H; Plass C; Risch A
Oncogene; 2013 Jul; 32(28):3329-38. PubMed ID: 22945651
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
